BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16732314)

  • 1. BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription.
    Brocke-Heidrich K; Ge B; Cvijic H; Pfeifer G; Löffler D; Henze C; McKeithan TW; Horn F
    Oncogene; 2006 Nov; 25(55):7297-304. PubMed ID: 16732314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-activator SRC-1 is dispensable for transcriptional control by STAT3.
    Cvijic H; Bauer K; Löffler D; Pfeifer G; Blumert C; Kretzschmar AK; Henze C; Brocke-Heidrich K; Horn F
    Biochem J; 2009 Apr; 420(1):123-32. PubMed ID: 19203349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells.
    Bauer K; Kretzschmar AK; Cvijic H; Blumert C; Löffler D; Brocke-Heidrich K; Schiene-Fischer C; Fischer G; Sinz A; Clevenger CV; Horn F
    Oncogene; 2009 Aug; 28(31):2784-95. PubMed ID: 19503092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An RNA-binding protein alphaCP-1 is involved in the STAT3-mediated suppression of NF-kappaB transcriptional activity.
    Nishinakamura H; Minoda Y; Saeki K; Koga K; Takaesu G; Onodera M; Yoshimura A; Kobayashi T
    Int Immunol; 2007 May; 19(5):609-19. PubMed ID: 17383969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functional NF-kappaB enhancer element in the first intron contributes to the control of c-fos transcription.
    Charital YM; van Haasteren G; Massiha A; Schlegel W; Fujita T
    Gene; 2009 Feb; 430(1-2):116-22. PubMed ID: 19026727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
    Gu L; Chiang KY; Zhu N; Findley HW; Zhou M
    Exp Hematol; 2007 Jun; 35(6):957-66. PubMed ID: 17533050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The LIM-homeodomain transcription factor LMX1B regulates expression of NF-kappa B target genes.
    Rascle A; Neumann T; Raschta AS; Neumann A; Heining E; Kastner J; Witzgall R
    Exp Cell Res; 2009 Jan; 315(1):76-96. PubMed ID: 18996370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.
    Buettner R; Huang M; Gritsko T; Karras J; Enkemann S; Mesa T; Nam S; Yu H; Jove R
    Mol Cancer Res; 2007 Aug; 5(8):823-32. PubMed ID: 17699108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGFR4 overexpression in pancreatic cancer is mediated by an intronic enhancer activated by HNF1alpha.
    Shah RN; Ibbitt JC; Alitalo K; Hurst HC
    Oncogene; 2002 Nov; 21(54):8251-61. PubMed ID: 12447688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear protein IkappaB-zeta inhibits the activity of STAT3.
    Wu Z; Zhang X; Yang J; Wu G; Zhang Y; Yuan Y; Jin C; Chang Z; Wang J; Yang X; He F
    Biochem Biophys Res Commun; 2009 Sep; 387(2):348-52. PubMed ID: 19595668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src activation of Stat3 is an independent requirement from NF-kappaB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cells.
    Trevino JG; Gray MJ; Nawrocki ST; Summy JM; Lesslie DP; Evans DB; Sawyer TK; Shakespeare WC; Watowich SS; Chiao PJ; McConkey DJ; Gallick GE
    Angiogenesis; 2006; 9(2):101-10. PubMed ID: 16871430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
    Duan H; Heckman CA; Boxer LM
    Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon alpha induces cell death through interference with interleukin 6 signaling and inhibition of STAT3 activity.
    Thyrell L; Arulampalam V; Hjortsberg L; Farnebo M; Grandér D; Pokrovskaja Tamm K
    Exp Cell Res; 2007 Nov; 313(19):4015-24. PubMed ID: 17880940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockage of interleukin-6 signaling with 6-amino-4-quinazoline synergistically induces the inhibitory effect of bortezomib in human U266 cells.
    Park J; Ahn KS; Bae EK; Kim BS; Kim BK; Lee YY; Yoon SS
    Anticancer Drugs; 2008 Sep; 19(8):777-82. PubMed ID: 18690088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin induces IL-8 expression via leptin receptor, IRS-1, PI3K, Akt cascade and promotion of NF-kappaB/p300 binding in human synovial fibroblasts.
    Tong KM; Shieh DC; Chen CP; Tzeng CY; Wang SP; Huang KC; Chiu YC; Fong YC; Tang CH
    Cell Signal; 2008 Aug; 20(8):1478-88. PubMed ID: 18501560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical and functional interactions between Daxx and STAT3.
    Muromoto R; Nakao K; Watanabe T; Sato N; Sekine Y; Sugiyama K; Oritani K; Shimoda K; Matsuda T
    Oncogene; 2006 Mar; 25(14):2131-6. PubMed ID: 16331268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinases.
    Hausherr A; Tavares R; Schäffer M; Obermeier A; Miksch C; Mitina O; Ellwart J; Hallek M; Krause G
    Oncogene; 2007 Jul; 26(34):4987-98. PubMed ID: 17310994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of azacitidine on interleukin-6 signaling and nuclear factor-kappaB activation and its in vitro and in vivo activity against multiple myeloma.
    Khong T; Sharkey J; Spencer A
    Haematologica; 2008 Jun; 93(6):860-9. PubMed ID: 18443271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An RNA biding protein, Y14 interacts with and modulates STAT3 activation.
    Ohbayashi N; Taira N; Kawakami S; Togi S; Sato N; Ikeda O; Kamitani S; Muromoto R; Sekine Y; Matsuda T
    Biochem Biophys Res Commun; 2008 Aug; 372(3):475-9. PubMed ID: 18503751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. REG Ialpha protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells.
    Sekikawa A; Fukui H; Fujii S; Ichikawa K; Tomita S; Imura J; Chiba T; Fujimori T
    Carcinogenesis; 2008 Jan; 29(1):76-83. PubMed ID: 18024479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.